Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Biodesix (BDSX) Income towards Parent Company: 2019-2025

Historic Income towards Parent Company for Biodesix (BDSX) over the last 6 years, with Sep 2025 value amounting to -$9.1 million.

  • Biodesix's Income towards Parent Company rose 14.17% to -$9.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$40.0 million, marking a year-over-year increase of 8.24%. This contributed to the annual value of -$42.8 million for FY2024, which is 15.96% up from last year.
  • As of Q3 2025, Biodesix's Income towards Parent Company stood at -$9.1 million, which was up 21.45% from -$11.6 million recorded in Q2 2025.
  • In the past 5 years, Biodesix's Income towards Parent Company ranged from a high of -$6.2 million in Q1 2021 and a low of -$18.8 million during Q1 2023.
  • For the 3-year period, Biodesix's Income towards Parent Company averaged around -$11.4 million, with its median value being -$10.6 million (2024).
  • As far as peak fluctuations go, Biodesix's Income towards Parent Company crashed by 292.35% in 2021, and later spiked by 44.05% in 2023.
  • Over the past 5 years, Biodesix's Income towards Parent Company (Quarterly) stood at -$13.2 million in 2021, then decreased by 24.78% to -$16.4 million in 2022, then spiked by 44.05% to -$9.2 million in 2023, then climbed by 8.67% to -$8.4 million in 2024, then rose by 14.17% to -$9.1 million in 2025.
  • Its Income towards Parent Company was -$9.1 million in Q3 2025, compared to -$11.6 million in Q2 2025 and -$10.8 million in Q1 2025.